Kategorien
-
Adhesives
5
Amines
92
Amino Acids
179
Analytical Reagents
668
Antibiotics
247
Bioactive Small Molecules
716
Aroma Chemicals
203
Biochemicals
1004
Boronic Acids
4
Buffers
96
Building Blocks
1759
Carbohydrates
176
Catalysts
96
Chiral Compounds
53
Coccus nucifera oil
0
Detergents
57
Diagnostic Raw Materials
257
Flavours and Fragrance Materials
202
Fluorinated Products
43
Furans
5
Gases in Solution
47
Grignard Reagents
18
HPLC Reagents
8
Imidazoles
17
Indoles
41
Inorganic Chemicals
321
Ion-Pair Reagents
24
Ligands
79
Organics
1295
Oxazoles
3
Peptide Reagents
90
Phenols
45
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
42
Reagents
97
Research Organics & Inorganics
753
Salts
281
Sealing Compounds
1
Sherclin
1
Solvents
121
Stains & Indicators
292
Sugars
63
Tailor-made solutions
1
Testing Standards
4
Uncategorised
90
Water Analysis
12
Escitalopram oxalate
(86905726 | 219861-08-2)
CAS: | 219861-08-2 |
---|---|
Molekularformel: | C20H21FN2O · C2H2O4 |
Molekulargewicht: | 414.43 |
Verfügbarkeit: | Auf Lager |
---|---|
Downloads: | | |
86905726-1g | 1g | £176.20 | |
Bulk Menge |
86905726-1g | 1g | €246.70 | |
Bulk Menge |
86905726-1g | 1g | $264.30 | |
Bulk Menge |
Sicherheitsdatenblatt
Analysezertifikat
Produktbeschreibung
Product Code | 86905726 | ||||
Product Name | Escitalopram oxalate | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 219861-08-2 | ||||
Molecular Formula | C20H21FN2O · C2H2O4 | ||||
Molecular Weight | 414.43 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 2932990090 |
Produktspezifikation
Melting Point | 148.5 - 152.5 ℃ | ||||
Specific rotation | +12 to +13.5 | ||||
Heavy metals | ≤10ppm | ||||
pH | 2.0 - 4.0 | ||||
Loss on Drying | ≤0.5% | ||||
Assay | ≥99.0% | ||||
Residue on Ignition | ≤0.1% | ||||
Individual impurity | ≤0.2% | ||||
Total Impurities | ≤0.5% | ||||
Appearance | White crystalline powder |
Sicherheitsinformation
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|